Logo

American Heart Association

  2
  0


Final ID:

Biomarkers for Cardiotoxicity Monitoring: Do We Really Need Them, Or Are They Just Extra Baggage? (Con)

  • Nohria, Anju  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
  • Asnani, Aarti  ( Beth Israel Deaconess , Arliton , Massachusetts , United States )
  • Author Disclosures:
    Anju Nohria: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bristol Myers Squibb:Active (exists now) ; Other (please indicate in the box next to the company name):Teledoc:Active (exists now) ; Other (please indicate in the box next to the company name):American College of Cardiology:Active (exists now) ; Consultant:Takeda Oncology:Active (exists now) ; Consultant:Regeneron:Past (completed) ; Consultant:Altathera:Past (completed) ; Consultant:AstraZeneca:Active (exists now) | Aarti Asnani: DO have relevant financial relationships ; Research Funding (PI or named investigator):Genentech:Active (exists now) ; Royalties/Patent Beneficiary:UpToDate:Active (exists now) ; Speaker:OncLive:Past (completed) ; Ownership Interest:Corventum:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Great Debates in Cardio-Oncology: Let's Agree to Disagree

Saturday, 11/16/2024 , 03:15PM - 04:30PM

Cardiovascular Seminar

More abstracts on this topic:
Biomarkers for Cardiotoxicity Monitoring: Do We Really Need Them, Or Are They Just Extra Baggage? (Pro)

Cardinale Daniela, Lopez-fernandez Teresa, Scherrer-crosbie Marielle

Guidelines in Cardio-Oncology: Ready for Prime Time? (Pro)

Plana Juan, Lyon Alexander, Van Der Meer Peter, Yang Eric

More abstracts from these authors:
Building a Cardio-oncology Program

Asnani Aarti, Barac Ana, Clasen Suparna

Optimizing Mouse Models of Doxorubicin Cardiomyopathy

Curtin Casie, Liu Jing, Basu Sandeep, Weitzman Benjamin, Wieke Jakob, Asnani Aarti

You have to be authorized to contact abstract author. Please, Login
Not Available